Hemangiol in infantile haemangioma: A paediatric post‐marketing surveillance drug study-Reference-Cited by-同舟云学术

Hemangiol in infantile haemangioma: A paediatric post‐marketing surveillance drug study

Published:2020-11-16 Issue:4 Volume:87 Page:1970-1980
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Socchi Floriane¹,Bigorre Michele²,Normandin Marion³,Captier Guillaume²,Bessis Didier⁴,Mondain Michel⁵,Blanchet Catherine⁵,Akkari Mohamed⁵,Amedro Pascal¹⁶,Gavotto Arthur¹⁶^ORCID

Affiliation:

1. Department of Paediatric and Congenital Cardiology, M3C Regional Reference Centre, Clinical Investigation Centre Montpellier University Hospital Montpellier France

2. Department of Paediatric Plastic Surgery Montpellier University Hospital Montpellier France

3. Department of Clinical Pharmacy Montpellier University Hospital Montpellier France

4. Department of Dermatology Montpellier University Hospital Montpellier France

5. Department of Paediatric ENT, Head and Neck Surgery Montpellier University Hospital Montpellier France

6. PhyMedExp, INSERM, CNRS University of Montpellier Montpellier France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14593

Reference50 articles.